Por: Slate Life December 05, 2022
Last July, in a little house in Ashburn, Virginia, Nichole Causey’s son told her he was going to take a shower. Causey, who owns a small business that does window tinting for homes, was working on her laptop in the living room; her son, Kyle, headed to the bathroom, which adjoined Nichole’s first-floor bedroom. A few minutes later, Nichole heard a strange sound coming from the bedroom, a kind of guttural grunt. When she went into the... + full article
The New York Times USA Health October 20, 2022
A Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm births.Makena has been in use for 11 years, and the panel’s vote was widely of... + más
FDA panel recommends pulling preterm birth drug from the market | The Boston Globe
FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC
The Boston Globe USA Nation October 20, 2022
A Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm birth.Makena has been in use for 11 years, and the panel’s vote was widely... + más
F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market | The New York Times
Los Angeles Times USA Science October 20, 2022
A federal advisory panel voted Wednesday to recommend that the only approved drug to prevent premature birth be removed from pharmacy shelves because studies have shown it does not work. The 14-to-1 vote came more than a decade after the Food and Drug Administration approved the... + más
FDA panel backs removal of unproven pregnancy drug | Portland Press Herald
CNBC USA Health October 19, 2022
An advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works.The recommendation, in a 14-1 vote, from the agency's Obstetrics, Reproductive and... + más
FDA panel backs removal of unproven pregnancy drug | WPLG Local 10
ALS drug wins FDA approval despite questionable data | ABC News
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | WPLG Local 10
New York Post USA Life September 30, 2022
A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of... + más
ALS drug gets FDA approval despite uncertainty about effectiveness | ABC7
CNBC USA Health September 29, 2022
The Food and Drug Administration on Thursday approved a controversial new drug designed to slow the progress of Lou Gehrig's disease, a victory for patients and advocates despite limited evidence that the drug is effective.The drug, from the Massachusetts-based , joins... + más
About iurex | Privacy Policy | Disclaimer |